Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genenta Science SPAFRA:K5F -6.90%37 3-Year EBITDA Growth Rate is 18.00% as of Dec. 2025. GuruFocus rates FRA:K5F with a GF Score™ of 37/100. The stock has 4 warning signs investors should review. Among 471 Conglomerates companies, Genenta Science SPA ranks better than 69.21% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 18.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -1.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genenta Science SPA was 18.00% per year. The lowest was -24.90% per year. And the median was -16.25% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Genenta Science SPA 3-Year EBITDA Growth Rate Related Terms
FRA:K5F vs VRTX, REGN, MRNA: 3-Year EBITDA Growth Rate Comparison
For the Conglomerates subindustry, Genenta Science SPA's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genenta Science SPA 3-Year EBITDA Growth Rate vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Genenta Science SPA's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Genenta Science SPA's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 18.00% mean?
Genenta Science SPA (FRA:K5F) has a 3-Year EBITDA Growth Rate of 18.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Genenta Science SPA and its competitors. According to the industry distribution chart, Genenta Science SPA ranks #145 out of 471 companies in the Conglomerates industry, placing it in the top 30.8%.
Is Genenta Science SPA's 3-Year EBITDA Growth Rate too high?
Genenta Science SPA's current 3-Year EBITDA Growth Rate is 18.00%. The Conglomerates industry median 3-Year EBITDA Growth Rate is 6.80. Genenta Science SPA's value of 18.00% is 164.7% above this industry median. Based on the distribution chart, Genenta Science SPA ranks #145 out of 471 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Genenta Science SPA has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's 3-Year EBITDA Growth Rate compare to VRTX and REGN?
According to the Conglomerates industry distribution chart, Genenta Science SPA ranks #145 out of 471 companies for 3-Year EBITDA Growth Rate. This puts Genenta Science SPA in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 6.80. Genenta Science SPA's value of 18.00% is 164.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Conglomerates company?
The median 3-Year EBITDA Growth Rate among Conglomerates companies is 6.80, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genenta Science SPA's current 3-Year EBITDA Growth Rate of 18.00% is 164.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Genenta Science SPA and its competitors. For the Conglomerates industry, the median 3-Year EBITDA Growth Rate is 6.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genenta Science SPA's current 3-Year EBITDA Growth Rate is 18.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (FRA:K5F) has a current 3-Year EBITDA Growth Rate of 18.00%. The current 3-Year EBITDA Growth Rate is 18.00% and 164.7% above the Conglomerates industry median of 6.80. Genenta Science SPA's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Genenta Science SPA (FRA:K5F), the current 3-Year EBITDA Growth Rate is 18.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
37GF Score
Get the complete analysis for FRA:K5F
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:K5F has been successfully added to your 
